Under construction – not a live service
Sign in
Not yet taking people in MozambiqueNo phase

Tests a community health system project for hypertension, diabetes and neglected diseases

Tests a community health system project in adults with high blood pressure or diabetes.

Plain-language title generated from the registry record
Registry title: Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries

Key facts

Where
Maputo, MozambiqueSee the site

Where in Mozambique

  • Eduardo Mondlane UniversityMaputo, MozambiqueNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Universidad Peruana Cayetano Heredia
Trial code
NCT06989502
Record updated
25 May 2025
Original description
The COHESION-I project will evaluate the effects of the co-creation intervention (2016 to 2019) and the co-design intervention (2023 to 2024) on improving (a) health system responsiveness, and (b) patient satisfaction, at the primary health care level, in Peru, Nepal and Mozambique, in relation to chronic diseases (hypertension, and diabetes mellitus), as well as specific neglected tropical diseases. Each intervention has been tailored to the context and characteristics of each one of the aforementioned low- and middle-income countries.Read full original descriptionShow less

GH Project: NIHR150261 - Implementation of the COmmunity HEalth System InnovatiON Project, COHESION-I

The COHESION-I project will evaluate the effects of the co-creation intervention (2016 to 2019) and the co-design intervention (2023 to 2024) on improving (a) health system responsiveness, and (b) patient satisfaction, at the primary health care level, in Peru, Nepal and Mozambique, in relation to chronic diseases (hypertension, and diabetes mellitus), as well as specific neglected tropical diseases. Each intervention has been tailored to the context and characteristics of each one of the aforementioned low- and middle-income countries.

For this quasi-experimental study, three arms were established: the co-creation (2016 to 2019) + co-design (2023 to 2024) arm; the co-design only (2023 to 2024) arm; and the control group (no intervention; usual care). The evaluation will be composed of four types of evaluations: quantitative; qualitative; economic; and process evaluation

Inclusion: Males or females aged 18 years and over, from the selected sites; Having used the health services in the previous three months; Diagnosis (or estimated risk) of diabetes mellitus type 2, hypertension, or neurocysticercosis; Must be able to listen to radio programs, or other audio material; Males or females aged 18 years and over, from the selected sites; Having used the health services in the previous three months; Must be able to listen to radio programs, or other audio material.

Exclusion: Diagnosis (or estimated risk) of diabetes mellitus type 2, hypertension, or neurocysticercosis; The criteria mentioned above refer solely to the quantitative evaluation. For the other types of evaluation, some different populations will be included (such as healthcare workers, local authorities and other stakeholders).

ClinicalTrials.gov NCT06989502